USFDA grants tentative approval to Lupin’s generic formulation for type 2 diabetes
时间:2024-06-26 10:24:57 阅读(143)
Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Dapagliflozin and Saxagliptin Tablets, 5 mg/5 mg and 10 mg/5 mg.
According to the company’s press statement, the approval has been granted to market a generic equivalent of Qtern Tablets, 5 mg/5 mg and 10 mg/5 mg of AstraZeneca AB. This product will be manufactured at Lupin’s Pithampur facility in India.
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT November 2023).
猜你喜欢
- Symbiosis International (Deemed University) invites applications for UG programmes
- Is Nifty 50 expensive- 22
- xpressTrain number 12415 Indore-New Delhi Intercity Superfast ExpressTrain number 12779 Vasco-De-Gama-Hazrat Nizamuddin ExpressTrain number 12615 Chennai-New Delhi Grand Trunk ExpressTrain number 12621 MGR Chennai Central-New Delhi Tamil Nadu ExpressTrain number 12723 Hyderabad-New Delhi TelanganaTrain number 12155 Habibganj-New Delhi Bhopal ExpressTrain number 11841 Gita Jayanti ExpressTrain number 12426 Jammu Tawi-New Delhi Rajdhani ExpressTrain number 12904 Golden Temple MailFoggy conditions to continue
The India Meteorological Department informed that dense to very dense fog conditions are very likely to continue in many parts of Punjab, Haryana, Chandigarh, and Delhi during the night and morning hours for the next three days.
“Dense to very dense fog conditions very likely to continue during night/morning hours in many parts of Punjab, Haryana, Chandigarh, Delhi during Dec 28-29 and in some parts for subsequent 3 days. Dense to very dense fog conditions very likely to continue during night/morning hours in some parts of Uttar Pradesh during Dec 28-29 and Dense fog in isolated pockets for subsequent 3 days,” the weather office said in its five day bulletin.
- Adani Ent zooms 31% in 2 days, group adds Rs 74k cr to mcap
- Investors back Retik Finance (RETIK) as project raises four million dollars, sells out presale Stage 3 in a jiffy
- 2023 could be a year of earnings downgrades- Christopher Wood
- ITC Hotels demerger at 1-10 ratio shows chairman Sanjiv Puri’s strategic foresight
- ISRO Chairman says Aditya L1 mission will reach its destination on January 6; reveals plans for Indian space station
- Tata Motors shares tank 5%, but analysts remain bullish; auto stock may be gearing for 26% rally